Children's Oncology Group - Insights
Learn how our team’s commitment and large testing menu helps in meeting the specific needs of Children’s Oncology Group patients.
Learn how our melanoma testing identifies variants in 17 genes associated with diagnosis, prognosis, and treatment guidance.
Lung Cancer Testing - Mayo Clinic Laboratories
Mayo Clinic Laboratories innovates at the speed of medical advancement, and offers comprehensive options for diagnostic, prognostic, and predictive lung cancer testing.
Pathology consultation - Insights
Learn more about how Mayo Clinic Laboratories consultative pathology practice, which is supported by more than 100 board-certified pathologists, can provide expertise on any case.
Connect with us at the 65th American Society of Hematology Annual Meeting and Exposition to learn how our evaluations can inform your clinical practice. Schedule a one-on-one session with our representatives.
Malabsorption disorders - Insights
Malabsorption syndrome encompasses several disorders that impact the ability of the small intestine to absorb macronutrients, micronutrients, or both. Because malabsorption syndrome can be caused by myriad factors, identifying the...
Helicobacter pylori, or H. pylori, is one of the world’s most common chronic bacterial infections. Estimated to impact 4.4 billion individuals globally, H. pylori affects 35% to 89% of children, depending the on the geographic region in...
Exocrine pancreatic insufficiency - Insights
Stool testing is a critical component of diagnosing exocrine pancreatic insufficiency (EPI), and Mayo Clinic Laboratories offers several tests to help clinicians evaluate these patients. A 48- or 72-hour stool fecal fat test is useful for...
Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D. - Insights
Maryam Shahi, M.D., explains how Mayo Clinic Laboratories' unique biomarker test (TEST ID: AFOLR) determines which patients would likely benefit from a new treatment for recurrent epithelial ovarian cancer. Disease recurrence is common, and...
Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D. - Insights
Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique assay identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal...
While the diagnostic criteria of celiac disease are well defined, symptoms are generally nonspecific. This fact, combined with the variety of available tests — each with a specific utility and interpretation — can make a diagnosis...
Autoimmune Liver Disease Testing - Mayo Clinic Laboratories
Our panel evaluates smooth muscle antibodies (SMA), antinuclear antibodies (ANA), and antimitochondrial antibodies (AMA) for patients with suspected autoimmune liver disease, specifically type 1 AIH or PBC or with liver disease of unknown...
Hepatocellular carcinoma - Insights
Hepatocellular carcinoma (HCC) is the third leading cause of death from cancer in the world. While HCC can be effectively treated in its early stages, most patients are not diagnosed until they are symptomatic and at higher grades and...
Our interactive learning modules encompass many of the necessary skills to further develop your knowledge and skills on your journey as a phlebotomist.
Mayo Clinic Laboratories’ fungal diagnostics test menu includes molecular and serological assays to aid in diagnosing a wide variety of fungal diseases, including those caused by Coccidioides possadasi/immitis, Histoplasma, Blastomyces, and...
Rapid hereditary breast cancer - Insights
Learn how our rapid breast cancer treatment panel delivers results in 10 to 14 days and detects 11 genes linked to lifetime breast cancer risk.
Find out how our BioPharma Diagnostics capabilities can support your precision medicine initiatives, from discovery to post market.
Axonal autoimmune neuropathies - Insights
Find out about our panel-based approach to axonal autoimmune neuropathies, which we recommend because of the overlap in clinical symptoms.
Autoimmune neurology evolution - Insights
Patients with autoimmune neurologic conditions deserve the best chance at an accurate diagnosis. These answers can make a real difference in a patient’s treatment and quality of life.
Understanding a Broken Heart: Genetic Testing After Sudden Cardiac Death - Insights
PACE/State of FL - Presentation Recording Coming Soon - Sudden cardiac death (SCD) is a devastating event that occurs unexpectedly, often without any prior symptoms. This webinar will discuss how postmortem genetic testing may be used in...
Check out Mayo Clinic Laboratories’ expert-developed biochemical and molecular testing to confirm a diagnosis of oligosaccharidosis.
Check out Mayo Clinic Laboratories’ expert-developed screening and panel testing for lysosomal disorders (LDs).
Optimizing Cancer Care: ASCO Guidelines for Germline Genetic Testing - Insights
PACE/State of FL - The latest ASCO guidelines for selection of germline genetic testing panels for cancer patients.
Jason Hipp, M.D., Ph.D., named chair of DLMP's new Division of Clinical Informatics - Insights
Dr. Hipp is a board-certified pathologist with fellowship training in pathology informatics, as well as artificial intelligence, machine, and deep-learning experience.
Reflex Test Guides Precise Care for Arsenic Exposure: Paul Jannetto, Ph.D. - Insights
Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' SPAS test identifies the form of arsenic present in patients with arsenic exposure. That information is important for determining the potential level of harm and for removing the...
4 statistics that showcase the broad impact of laboratory medicine - Insights
Medical Laboratory Professionals Week is a time to appreciate the profound impact of laboratory medicine on healthcare and innovation.
Christmas and New Year's specimen shipment alert - Insights
Due to the Christmas and New Year's holiday's (recognized on Saturday, December 25th, and Saturday, January 1st ), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and...
New Test Options for NTRK Gene Fusions - Insights
The presence NTRK gene fusions is one of the eligibility requirements for the recently FDA-approved therapy Vitrakvi (larotrectinib), a therapy indicated in adult and pediatric patients with solid tumors regardless of the type of tumor....
Mayo Clinic Laboratory and pathology research roundup: March 15 - Insights
This Feature Includes: Assessing the contribution of rare variants to complex trait heritability from whole-genome sequence data.
Metagenomic Sequencing - A Tool for Diagnosis of Central Nervous System Infection - Insights
PACE/State of FL - Metagenomic sequencing for diagnosing central nervous system infection. Content will be shared regarding technical details, clinical applications, and results interpretation, drawing on both current literature and...
Manage to Reimbursement - Insights
PACE/State of FL - This webinar will provide a methodology for laboratory leadership to review their test menu for assays that most impact the financial health of their laboratory.
The Quality Auditor Role - Assessing the Laboratory - Insights
PACE/State of FL - Internal assessments are integral to a laboratory’s quality management system (QMS).
Sickle cell disease: How new technologies are transforming patient lives - Insights
PACE/State of FL - The current knowledge regarding sickle cell disease from its genetic cause to the myriads of effects it can have for affected individuals.
T-cell Lymphoma [Test in Focus] - Insights
Andrew Feldman, M.D., discusses the different tools and techniques Mayo Clinic Laboratories uses to accurately diagnose and classify T-cell lymphomas to help provide clinicians with the diagnostic answers they need to treat their patients.
Gastrointestinal Pathogen Panel, PCR, Feces [Test in Focus] - Insights
The new Gastrointestinal Pathogen Panel, PCR, Feces test is now available to the Mayo Clinic practice and Mayo Medical Laboratories clients.
Testing to Identify Clinically Significant Chromosomal Abnormalities - Insights
This week's featured chromosomal microarray test in focus is presented by William Sukov, M.D., a pathologist and cancer geneticist at Mayo Clinic. He discusses when this test should be used for patients with renal tumors.
Autoimmune Profile Updates [Test in Focus] - Insights
Andrew McKeon, M.B., B.Ch., M.D., discusses updates that are being made to Mayo Clinic Laboratories' autoimmune profile that will remove some antibodies from those profiles. He describes the rationale behind the updates, reviews which...
For people with encephalitis, rapid treatment of their acute brain inflammation is critical for avoiding devastating physical and cognitive deficits. But appropriate treatment requires identifying the culprit causing the symptoms.
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 17 - Insights
This week’s Research Roundup highlights the risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics.
Research Roundup Archives - Page 19 of 28 - Insights
Skip to Content MayoACCESS MayoLINK...
Mayo Clinic Laboratory and Pathology Research Roundup: Oct. 15 - Insights
This week’s Research Roundup highlights paraneoplastic neuronal intermediate filament autoimmunity.
Mayo Clinic Laboratory and Pathology Research Roundup: Nov. 19 - Insights
This week’s Research Roundup highlights the association of apolipoprotein E ε4 with transactive response DNA-binding protein 43.
Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 10 - Insights
This week’s Research Roundup highlights hepatocellular carcinoma detection by plasma methylated DNA through a discovery, phase I pilot, and phase II clinical validation.
PathWays Case Studies: Nov. 2018 - Insights
Mayo Clinic laboratory experts share three case studies in this month’s “PathWays” post and are challenging you to test your Clinical Pathology, Molecular Diagnostic, Hematopathology, and Dermatology pathology knowledge. Review the cases,...
Mayo Clinic Start-up Earns World Economic Forum Award - Insights
Mayo Clinic startup company Vineti developed first-of-its-kind software package tracking for cell therapies. Vineti’s groundbreaking product captured a World Economic Forum Technology Pioneer Award in the field of health.
COVID-19's dangerous connection to coagulopathy - Insights
Nahla Heikal, M.D., co-director of Mayo Clinic's Special Coagulation Laboratory, addresses the connection between COVID-19 and coagulopathy.
Training Clinical Chemistry: Where Do We Go from Here? - Insights
Justin Kreuter, M.D., discusses training in clinical chemistry, highlighting his own experiences and challenges and offering valuable resources for future pathology residents.
COVID-19 Laboratory Update: July 7 | Minnesota Partnership - Insights
Minnesota reaches milestone of 20,000 daily test capacity Minnesota Governor Tim Walz has announced the state has completed more than half a million
Discussion as Pedagogical Strategy - Insights
Discussion is an effective pedagogical strategy to facilitate a learning experience and assess understanding. Carrie Bowler, Program Manager of Staff Development in the Department of Laboratory Medicine and Pathology, discusses the benefits...
Some Interesting Applications in the Medical Laboratory Science Program - Insights
Elizabeth Atneosen, a student in the Mayo Clinic Medical Laboratory Science program, discusses interesting applications she has learned thus far in the program.